Cited by 730Platelet Disorders and TreatmentsBlood Coagulation and Thrombosis MechanismsReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 167 of the 168 references it cites were found in a registry or an index.

Activation of Platelet Function Through G Protein–Coupled Receptors

Offermanns, Stefan·2006·Circulation Research

DOI 10.1161/01.res.0000251742.71301.16

Open this paper in CoChat — free account

Abstract

Because of their ability to become rapidly activated at places of vascular injury, platelets are important players in primary hemostasis as well as in arterial thrombosis. In addition, they are also involved in chronic pathological processes including the atherosclerotic remodeling of the vascular system. Although primary adhesion of platelets to the vessel wall is largely independent of G protein–mediated signaling, the subsequent recruitment of additional platelets into a growing platelet thrombus requires mediators such as ADP, thromboxane A 2 , or thrombin, which act through G protein–coupled receptors. Platelet activation via G protein–coupled receptors involves 3 major G protein–mediated signaling pathways that are initiated by the activation of the G proteins G q , G 13 , and G i . This review summarizes recent progress in understanding the mechanisms underlying platelet activation and thrombus extension via G protein–mediated signaling pathways.

Integrity signals

Registry

Crossref · 10.1161/01.res.0000251742.71301.16

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
RHO GTPASES: Biochemistry and Biology
Jaffe, A. B., & Hall, A. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.020604.150721 · Cited by 3,009
The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Seven-transmembrane receptors
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712
Platelets in atherothrombosis
Ruggeri, Z. M. (2002) · Nature Medicine · doi:10.1038/nm1102-1227 · Cited by 1,605
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Platelets in inflammation and atherogenesis
Gawaz, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27196 · Cited by 1,484

Show all 168 references

Research works printed but not linked: 5

10.1161/circ.100.15.1667 · DOI
10.1161/circ.104.10.1176 · DOI
10.1161/res.86.2.131 · DOI
10.1182/blood.V96.1.50 · DOI
10.1172/JCI200420267 · DOI

Sorted by citations

Items 201–300 of 730

CD148 enhances platelet responsiveness to collagen by maintaining a pool of active Src family kinases
Ellison, S. M., Mori, J., Barr, A., & Senis, Y. A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03865.x · Cited by 35
Limitations of current therapies to prevent thrombosis: a need for novel strategies
Fabre, J., & Gurney, M. E. (2009) · Molecular BioSystems · doi:10.1039/b914375k · Cited by 36
P2Y12receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation
Chan, M. V., Knowles, R., Lundberg, M. H., Tucker, A. T., Mohamed, N. A., Kirkby, N. S., Armstrong, P. C. J., Mitchell, J. A., & Warner, T. D. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12826 · Cited by 36
RGS10 Negatively Regulates Platelet Activation and Thrombogenesis
Hensch, N. R., Karim, Z. A., Druey, K. M., Tansey, M. G., & Khasawneh, F. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165984 · Cited by 34
Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood
Bijak, M., Szelenberger, R., Saluk, J., & Nowak, P. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.002 · Cited by 34
Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y1 and P2Y12 receptors
Liu, X., Gao, Z., Wu, Y., Stevens, R. C., Jacobson, K. A., & Zhao, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-26577-0 · Cited by 34
Bioactive peptides and proteins as alternative antiplatelet drugs
Rengasamy, K. R. R., Khan, H. Z., Ahmad, I., Lobine, D., Mahomoodally, M. F., Suroowan, S., Hassan, S. T. S., Xu, S., Patel, S. V., Daglia, M., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21579 · Cited by 33
Redox regulation of platelet function and thrombosis
Jiang, H., Nechipurenko, D. Y., Panteleev, M. A., Xu, K., & Qiao, J. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.02.018 · Cited by 33
Human platelet pathology related to defects in the G-protein signaling cascade
Geet, C. V., Izzi, B., Labarque, V., & Freson, K. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03399.x · Cited by 33
Regulation of Platelet Function by Orai, STIM and TRP
Berna‐Erro, A., Jardín, I., Smani, T., & Rosado, J. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-26974-0_8 · Cited by 34
Platelet function testing at low platelet counts: When can you trust your analysis?
Boknäs, N., Macwan, A. S., Södergren, A. L., & Ramström, S. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12193 · Cited by 33
Platelet activation and reactivity in the convalescent phase of ischaemic stroke
Różalski, M., Luzak, B., Michalak, S., Kozubski, W. P., Watała, C. W., & Łukasik, M. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-08-0599 · Cited by 33
A Flow Cytometric Analysis of the Inhibition of Platelet Reactivity Due to Nitrite Reduction by Deoxygenated Erythrocytes
Akrawinthawong, K., Park, J. W., Piknova, B., Sibmooh, N., Fucharoen, S., & Schechter, A. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092435 · Cited by 32
Repeated platelet activation and the potential of previously activated platelets to contribute to thrombus formation
Simone, I. D., Baaten, C. C. F. M. J., Gibbins, J. M., Cate, H. T., Heemskerk, J. W. M., Jones, C. I., & van der Meijden, P. E. J. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.01.006 · Cited by 32
A critical role of thrombin/PAR-1 in ADP-induced platelet secretion and the second wave of aggregation
Jiang, L., Xu, C., Yu, S., Liu, P., Luo, D., Zhou, Q., Gao, C., & Hu, H. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12168 · Cited by 32
Both G protein–coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice
Mwiza, J.-M., Lee, R. H., Paul, D. S., Holle, L. A., Cooley, B. C., Nieswandt, B., Schug, W. J., Kawano, T., Mackman, N., Wolberg, A. S., et al. (2022) · Blood · doi:10.1182/blood.2022015787 · Cited by 33
The Toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade
Fälker, K., Klarström-Engström, K., Bengtsson, T., Lindahl, T. L., & Grenegård, M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.011 · Cited by 32
Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies
Chen, J., Tan, K., Zhou, H., Lo, H.-F., Roux, D. T., Liddington, R., & Diacovo, T. G. (2007) · Nature Biotechnology · doi:10.1038/nbt1373 · Cited by 32
Characterization of UBO-QIC as a Gαqinhibitor in platelets
Inamdar, V. V., Patel, A., Manne, B. K., Dangelmaier, C., & Kunapuli, S. P. (2015) · Platelets · doi:10.3109/09537104.2014.998993 · Cited by 31
Gq pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets
Badolia, R., Inamdar, V. V., Manne, B. K., Dangelmaier, C., Eble, J. A., & Kunapuli, S. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791012 · Cited by 31
Platelet hyperreactivity and a prothrombotic phenotype in mice with a gain‐of‐function mutation in phospholipase Cγ2
Elvers, M., Pozgaj, R., Pleines, I., May, F., Kuijpers, M. J. E., Heemskerk, J. W. M., Yu, P., & Nieswandt, B. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03838.x · Cited by 31
Identification of an Interaction between the TPα and TPβ Isoforms of the Human Thromboxane A2 Receptor with Protein Kinase C-related Kinase (PRK) 1
Turner, E. C., Kavanagh, D., Mulvaney, E. P., McLean, C., Wikström, K., Reid, H. M., & Kinsella, B. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.181180 · Cited by 31
Retracted
Analysis of platelet function and dysfunction
Jurk, K. (2014) · Hämostaseologie · doi:10.5482/hamo-14-09-0047 · Cited by 31
Antiplatelet Pretreatment does not Increase Hematoma Volume in Experimental Intracerebral Hemorrhage
Lauer, A., Schlunk, F., Cott, E. M. V., Steinmetz, H., Lo, E. H., & Foerch, C. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.22 · Cited by 31
Disabled-2 Is Required for Efficient Hemostasis and Platelet Activation by Thrombin in Mice
Tsai, H.-J., Huang, C., Chang, Y.-W., Huang, D.-Y., Lin, C.-C., Cooper, J. A., Cheng, J.-C., & Tseng, C. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.302602 · Cited by 31
Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-1
Chisholm, M. M., Quigley, L., McMahon, J. B., Mori, T., Giomarelli, B., Washington, A. V., & McVicar, D. W. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-08-0456 · Cited by 31
The soluble protease ADAMDEC1 released from activated platelets hydrolyzes platelet membrane pro-epidermal growth factor (EGF) to active high-molecular-weight EGF
Chen, R., Jin, G., & McIntyre, T. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.771642 · Cited by 30
The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics
Malladi, N., Alam, M. J., Maulik, S. K., & Banerjee, S. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106766 · Cited by 33
Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation
Schinner, E., Salb, K., & Schlossmann, J. (2011) · Platelets · doi:10.3109/09537104.2010.544151 · Cited by 31
Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia
Krajewski, S., Kurz, J., Neumann, B., Greiner, T.-O., Stolz, A., Balkau, B., Peter, K., Unertl, K. E., Wendel, H. P., & Straub, A. (2012) · British Journal of Anaesthesia · doi:10.1093/bja/aer518 · Cited by 30
Humanized Mouse Model of Thrombosis Is Predictive of the Clinical Efficacy of Antiplatelet Agents
Magallon, J., Chen, J., Rabbani, L. E., Dangas, G., Yang, J., Bussel, J. B., & Diacovo, T. G. (2011) · Circulation · doi:10.1161/circulationaha.110.951970 · Cited by 32
Thrombin Receptor Antagonists for the Treatment of Atherothrombosis
Leonardi, S., Tricoci, P., & Becker, R. C. (2010) · Drugs · doi:10.2165/11538060-000000000-00000 · Cited by 29
The Role of Calpain-Myosin 9-Rab7b Pathway in Mediating the Expression of Toll-Like Receptor 4 in Platelets: A Novel Mechanism Involved in α-Granules Trafficking
Tsai, J.-C., Lin, Y., Huang, C., Lin, C., Tsai, Y.-T., Shih, C.-M., Lee, C.-Y., Chen, Y., Li, C., Chang, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085833 · Cited by 29
Inhibition of platelet GPIIb–IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia
Guyader, A. L., Pacheco, G. S., Seaver, N., Davis‐Gorman, G., Copeland, J. G., & McDonagh, P. F. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.06.003 · Cited by 29
Aspirin eugenol ester inhibits agonist-induced platelet aggregation in vitro by regulating PI3K/Akt, MAPK and Sirt 1/CD40L pathways
Shen, D., Yang, Y., Kong, X., Ma, N., Liu, X., Li, S., Jiao, Z., Qin, Z., Huang, M., & Li, J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.032 · Cited by 31
Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target
Benson, T. W., Pike, M., Spuzzillo, A. R., Hicks, S. M., Ali, S. A., Pham, M., Mix, D., Brunner, S. I., Wadding-Lee, C., Conrad, K. A., et al. (2024) · Blood · doi:10.1182/blood.2023021655 · Cited by 28
IL-6 as a Mediator of Platelet Hyper-Responsiveness
Webb, C. E., Vautrinot, J., & Hers, I. (2025) · Cells · doi:10.3390/cells14110766 · Cited by 34
Influence of calcium salts and bovine thrombin on growth factor release from equine platelet-rich gel supernatants
Giraldo, C. E., Álvarez, M. E., & Carmona, J. U. (2016) · Veterinary and Comparative Orthopaedics and Traumatology · doi:10.3415/vcot-16-02-0026 · Cited by 28
Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets
de la Peña, N. C., Gutiérrez‐Aguilar, M., Hernández‐Reséndiz, I., Marín‐Hernández, Á., & Rodríguez‐Enríquez, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182374 · Cited by 28
GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets
Chen, X., Gupta, S., Cooper, M., DeHelian, D., Zhao, X., Naik, M. U., Wurtzel, J. G. T., Stalker, T. J., Goldfinger, L. E., Benovic, J., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000467 · Cited by 28
Saponins as Modulators of the Blood Coagulation System and Perspectives Regarding Their Use in the Prevention of Venous Thromboembolic Incidents
Olas, B., Urbańska, K., & Bryś, M. (2020) · Molecules · doi:10.3390/molecules25215171 · Cited by 28
Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
Turolo, S., Edefonti, A., Mazzocchi, A., Syrén, M., Morello, W., Agostoni, C. V., & Montini, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115452 · Cited by 28
Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb/IIIa dependent platelet activation
Stegner, D., Göb, V., Krenzlin, V., Beck, S., Hemmen, K., Schuhmann, M. K., Schörg, B. F., Hackenbroch, C., May, F., Burkard, P., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00017-1 · Cited by 28
Abacavir induces platelet-endothelium interactions by interfering with purinergic signalling: A step from inflammation to thrombosis
Álvarez, Á., Ríos‐Navarro, C., Blanch‐Ruiz, M. A., Collado‐Díaz, V., Andújar, I., Martínez-Cuesta, M. Á., Orden, S., & Esplugues, J. V. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.03.001 · Cited by 27
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist
Adams, J. W., Ramirez, J., Ortuno, D., Shi, Y., Thomsen, W. J., Richman, J. G., Morgan, M. E., Dosa, P. I., Teegarden, B. R., AL‐SHAMMA, H. A., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.056 · Cited by 26
The GRKs Reactome: Role in Cell Biology and Pathology
Chaudhary, P. K., & Kim, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073375 · Cited by 26
Platelet functional responses and signalling: the molecular relationship. Part 1: responses.
Sveshnikova, A. N., Stepanyan, M. G., & Panteleev, M. A. (2021) · System Biology and Physiology Reports · doi:10.52455/sbpr.01.202101014 · Cited by 26
Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4–Mediated Thrombin Resistance
Gnanenthiran, S. R., Pennings, G. J., Reddel, C. J., Campbell, H., Kockx, M., Hamilton, J. R., Chen, V. M. Y., & Kritharides, L. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.316772 · Cited by 31
Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology
Zheng, T. J., Parra‐Izquierdo, I., Reitsma, S. E., Heinrich, M. C., Larson, M. K., Shatzel, J. J., Aslan, J. E., & McCarty, O. J. T. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00040.2022 · Cited by 27
The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets
Kumm, E. J., Pagel, O., Gambaryan, S. P., Walter, U., Zahedi, R. P., Smolenski, A., & Jurk, K. (2020) · Cells · doi:10.3390/cells9020472 · Cited by 27
BLOOD PLATELETS AS ACTIVATORS AND REGULATORS OF INFLAMMATORY AND IMMUNE REACTIONS. PART 1. BASIC CHARACTERISTICS OF PLATELETS AS INFLAMMATORY CELLS
Serebryanaya, N. B., Николаевич, Ш. С., Fomicheva, E. E., & Павлович, Я. П. (2018) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2018-6-785-796 · Cited by 26
Effect of pH on the interaction between zwitterions and titanium oxide
Tanaka, Y., Saito, H., Tsutsumi, Y., Doi, H., Nomura, N., Imai, H., & Hanawa, T. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2008.10.042 · Cited by 25
The Future of Antiplatelet Therapy in Cardiovascular Disease
Patrono, C., & Rocca, B. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-020209-171035 · Cited by 25
Signaling Pathways of Receptors Involved in Platelet Activation andShedding of These Receptors in Stored Platelets
Amelirad, A., Shamsasenjan, K., Akbarzadehlaleh, P., & Sarvar, D. P. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.005 · Cited by 25
Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell
Morotti, A., Barale, C., Melchionda, E., & Russo, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911446 · Cited by 25
Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradation
Li, J., Qu, J., Shi, Y., Perfetto, M., Ping, Z., Christian, L., Niu, H., Mei, S., Zhang, Q., Yang, X., et al. (2017) · Scientific Reports · doi:10.1038/srep43173 · Cited by 24
Immobilized collagen prevents shedding and induces sustained GPVI clustering and signaling in platelets
Pallini, C., Pike, J. A., O’Shea, C., Andrews, R. K., Gardiner, E. E., Watson, S. P., & Poulter, N. S. (2021) · Platelets · doi:10.1080/09537104.2020.1849607 · Cited by 25
Platelet Shape Change
Aslan, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_24 · Cited by 23
Platelet Signaling in Primary Haemostasis and Arterial Thrombus Formation: Part 2
Scharf, R. E. (2018) · Hämostaseologie · doi:10.1055/s-0038-1675149 · Cited by 23
cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets
Makhoul, S., Trabold, K., Gambaryan, S. P., Tenzer, S., Pillitteri, D., Walter, U., & Jurk, K. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0428-1 · Cited by 23
Involvement of P2Y12 receptors in a nitroglycerin‐induced model of migraine in male mice
Gölöncsér, F., Baranyi, M., Iring, A., Hricisák, L., Otrokocsi, L., Benyó, Z., & Sperlágh, B. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15641 · Cited by 24
SCH 530348: A Novel Oral Thrombin Receptor Antagonist
Bonaca, M. P., & Morrow, D. A. (2009) · Future Cardiology · doi:10.2217/fca.09.27 · Cited by 23
Anti-platelet and anti-thrombotic effect of a traditional herbal medicine Kyung-Ok-Ko
Kim, T., Lee, K. M., Hong, N. D., & Jung, Y. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.11.040 · Cited by 23
Design, Virtual Screening, and Synthesis of Antagonists of αIIbβ3 as Antiplatelet Agents
Полищук, П. Г., Samoylenko, G. V., Khristova, T. M., Krysko, O. L., Кабанова, Т. А., Kabanov, V. M., Kornylov, A. Y., Klimchuk, O., Langer, T., Andronati, S. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00865 · Cited by 23
Novel Aspects Targeting Platelets in Atherosclerotic Cardiovascular Disease—A Translational Perspective
Huseynov, A., Reinhardt, J., Chandra, L., Dürschmied, D., & Langer, H. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076280 · Cited by 24
Enhancement of Platelet Aggregation by Ursolic Acid and Oleanolic Acid
Kim, M., Han, C.-H., & Lee, M. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.008 · Cited by 22
Arterial thrombus formation
Hagedorn, I., Vögtle, T., & Nieswandt, B. (2010) · Hämostaseologie · doi:10.1055/s-0037-1619045 · Cited by 22
Systems biology of platelet-vessel wall interactions
Diamond, S. L., Purvis, J. E., Chatterjee, M. S., & Flamm, M. H. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00229 · Cited by 22
Platelet Activation, and Antiplatelet Targets and Agents
Xiang, Y., Xia, Y., Gao, X., Shang, H., Kang, L., & Zhang, B.-L. (2008) · Drugs · doi:10.2165/00003495-200868120-00004 · Cited by 22
Platelets and their role in cancer evolution and immune system.
Karachaliou, N., Pilotto, S., Bria, E., & Rosell, R. (2015) · PubMed Central · doi:10.3978/j.issn.2218-6751.2015.10.09 · Cited by 21
Retracted
Altered microtubule equilibrium and impaired thrombus stability in mice lacking RanBP10
Meyer, I., Kunert, S., Schwiebert, S., Hagedorn, I., Italiano, J. E., Dütting, S., Nieswandt, B., Bachmann, S., & Schulze, H. (2012) · Blood · doi:10.1182/blood-2012-01-401737 · Cited by 24
Silencing of a Targeted Protein in In Vivo Platelets Using a Lentiviral Vector Delivering Short Hairpin RNA Sequence
Ohmori, T., Kashiwakura, Y., Ishiwata, A., Madoiwa, S., Mimuro, J., & Sakata, Y. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149872 · Cited by 22
The association of thromboxane A2 receptor with lipid rafts is a determinant for platelet functional responses
Moscardó, A., Vallés, J., Latorre, A., & Santos, M. T. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.06.057 · Cited by 21
ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors
Anderson, R., Theron, A. J., Steel, H. C., Nel, J. G., & Tintinger, G. R. (2020) · Pharmaceuticals · doi:10.3390/ph13120420 · Cited by 21
Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation
Passacquale, G., & Ferro, A. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03906.x · Cited by 21
Mutational analysis of residues important for ligand interaction with the human P2Y12 receptor
Mao, Y., Zhang, L., Jin, J., Ashby, B., & Kunapuli, S. P. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.023 · Cited by 21
Feedback Regulation of Syk by Protein Kinase C in Human Platelets
Makhoul, S., Dorschel, S., Gambaryan, S. P., Walter, U., & Jurk, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010176 · Cited by 20
GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12
Zhao, X., Cooper, M., Michael, J. V., Yarman, Y., Baltz, A., Chuprun, J. K., Koch, W. J., McKenzie, S. E., Tomaiuolo, M., Stalker, T. J., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007007 · Cited by 20
Involvement of neutrophils in thrombus formation in living mice
Darbousset, R., Mezouar, S., Dignat‐George, F., Panicot‐Dubois, L., & Dubois, C. (2014) · Pathologie Biologie · doi:10.1016/j.patbio.2013.11.002 · Cited by 21
SIRT1 prevents pulmonary thrombus formation induced by arachidonic acid via downregulation of PAF receptor expression in platelets
Kim, Y. H., Bae, J. U., Kim, I., Chang, C. L., Oh, S. O., & Kim, C. D. (2016) · Platelets · doi:10.1080/09537104.2016.1190005 · Cited by 20
Physiology, Thromboxane A2
Rucker, D., & Dhamoon, A. S. (2020) · StatPearls · Cited by 20
Increased Serum Thromboxane A2 and Prostacyclin but Lower Complement C3 and C4 Levels in COVID-19: Associations with Chest CT Scan Anomalies and Lowered Peripheral Oxygen Saturation
Al‐Hakeim, H. K., Al-Hamami, S. A., Almulla, A. F., & Maes, M. H. J. (2021) · COVID · doi:10.3390/covid1020042 · Cited by 20
Ultra-high-throughput Ca2+ assay in platelets to distinguish ITAM-linked and G-protein-coupled receptor activation
Fernández, D. I., Provenzale, I., Cheung, H. Y. F., van Groningen, J., Tullemans, B. M. E., Veninga, A., Dunster, J. L., Honarnejad, S., van den Hurk, H., Kuijpers, M. J. E., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103718 · Cited by 20
Developmental Differences in Platelet Inhibition Response to Prostaglandin E1
Palma‐Barqueros, V., Diaz, J. M. T., Caparrós-Pérez, E., Mota-Pérez, N., Bohdan, N., Llanos, M. C., Begonja, A. J., Sola-Visner, M. C., Vicente, V., Teruel‐Montoya, R., et al. (2019) · Neonatology · doi:10.1159/000504173 · Cited by 19
Antiplatelet drugs and liver fibrosis
Czajka, P., Przybyłkowski, A. M., Nowak, A., Postula, M. A., Wolska, M., Mirowska-Guzel, D. M., Członkowska, A., & Eyileten, C. (2021) · Platelets · doi:10.1080/09537104.2021.1883574 · Cited by 19
Microbiota‐related metabolites fueling the understanding of ischemic heart disease
Fan, Y., Ying, J., Ma, H., & Cui, H. (2023) · iMeta · doi:10.1002/imt2.94 · Cited by 18
High-throughput assessment identifying major platelet Ca2+ entry pathways via tyrosine kinase-linked and G protein-coupled receptors
Cheung, H. Y. F., Zou, J., Tantiwong, C., Fernández, D. I., Huang, J., Ahrends, R., Roest, M., Cavill, R., Gibbins, J., & Heemskerk, J. W. M. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102738 · Cited by 19
Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease
Park, Y., Franchi, F., Rollini, F., & Angiolillo, D. J. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0208 · Cited by 19
Proteinase-activated receptors (PARs) as targets for antiplatelet therapy
Cunningham, M., McIntosh, K., Bushell, T. J., Sloan, G., & Plevin, R. J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150282 · Cited by 19
Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects
Morikawa, Y., Kato, H., Kashiwagi, H., Nishiura, N., Akuta, K., Honda, S., Kanakura, Y., & Tomiyama, Y. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.12.014 · Cited by 19
Computational and Functional Evaluation of a Microfluidic Blood Flow Device
Gilbert, R., Park, H., Rasponi, M., Redaelli, A. C. L., Gellman, B. N., Dasse, K. A., & Thorsen, T. (2007) · ASAIO Journal · doi:10.1097/mat.0b013e3180a5e8ab · Cited by 19
Current antithrombotic agents for acute coronary syndromes: Focus on bleeding risk
Bassand, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.10.104 · Cited by 19
Perioperative management of the patient with a coronary stent
Popescu, W. M. (2009) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3283340b1a · Cited by 18
Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets
Bijak, M., Szelenberger, R., Dziedzic, A., & Saluk, J. (2018) · Molecules · doi:10.3390/molecules23020374 · Cited by 18
Assessment of neonatal, cord, and adult platelet granule trafficking and secretion
Ngo, A. T. P., Sheriff, J., Rocheleau, A. D., Bucher, M., Jones, K. R., Sepp, A.-L. I., Malone, L. E., Zigomalas, A., Maloyan, A., Bahou, W. F., et al. (2019) · Platelets · doi:10.1080/09537104.2019.1573314 · Cited by 18
Synthetic Flavonoids as Novel Modulators of Platelet Function and Thrombosis
Vallance, T. M., Ravishankar, D., Albadawi, D. A. I., Osborn, H. M. I., & Vaiyapuri, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123106 · Cited by 18
Off-target effect of the Epac agonist 8-pCPT-2′-O-Me-cAMP on P2Y12 receptors in blood platelets
Herfindal, L., Nygaard, G., Kopperud, R., Krakstad, C., Døskeland, S. O., & Selheim, F. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.007 · Cited by 18
The Gq and G12 Families of Heterotrimeric G Proteins Report Functional Selectivity
Zhang, L., Brass, L. F., & Manning, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050906 · Cited by 18
The green tea extract epigallocatechin gallate inhibits human platelet function but not plasma coagulation
Mosawy, S., Gaiz, A. A., Karaksha, A., & Singh, I. (2016) · Griffith Research Online · doi:10.5923/j.ijpt.20160502.01 · Cited by 17
Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling Pathways
López-Vílchez, I., Jerez, D., Díaz‐Ricart, M., Navarro, V., Zafar, M. U., Zamorano‐León, J. J., López-Farré, A. J., Badimón, J. J., Gastó, C., & Escolar, G. (2017) · Thrombosis and Haemostasis · doi:10.1160/th17-04-0288 · Cited by 18

Authors: Offermanns, S.
Affiliations: Heidelberg University (DE)
Corresponding author: Offermanns, Stefan
ORCID: Offermanns, Stefan
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2006-12-08
Volume: 99
Issue: 12
Pages: 1293-1304
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/01.res.0000251742.71301.16
OpenAlex: W2161488081
Cited by: 725
References: 168
Citations by year: 2026: 32 · 2025: 33 · 2024: 37 · 2023: 30 · 2022: 52 · 2021: 42 · 2020: 37 · 2019: 38 · 2018: 23 · 2017: 53 · 2016: 34 · 2015: 45 · 2014: 33 · 2013: 46 · 2012: 29
FWCI: 3.23
Type: journal article
Language: en
Open access: closed
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Circulation Research
Topics: Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: platelet activation, G protein-coupled receptors, G protein signaling, Gq, G13, Gi, thrombus extension, primary hemostasis, arterial thrombosis, atherosclerosis, thromboxane A2, thrombin, ADP, platelet adhesion
MeSH terms: Animals, Blood Platelets, Humans, Thrombosis, Platelet Activation, Receptors, G-Protein-Coupled

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Activation of Platelet Function Through G Protein–Coupled Receptors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks